BioRestorative Therapies, Inc. | Business Contracts

Plan of Merger (Filed With SEC on January 5, 2023)

Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and David Rosa (Filed With SEC on March 30, 2022)

Lease Amendment, dated as of June 4, 2019, between 50 Republic Road, LLC and BioRestorative Therapies, Inc (Filed With SEC on March 18, 2021)

Amendment to Silva Employment Agreement, dated January 13, 2020 (Filed With SEC on March 18, 2021)

UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF NEW YORK (Filed With SEC on November 5, 2020)

Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and Patrick F. Williams (Filed With SEC on March 30, 2022)

Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and Nickolay Kukekov (Filed With SEC on March 30, 2022)

Amendment No. 2 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and Francisco Silva (Filed With SEC on March 30, 2022)

Amendment No. 2 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and Lance Alstodt (Filed With SEC on March 30, 2022)

Common Stock Purchase Warrant, dated November 9, 2021, issued by BioRestorative Therapies, Inc. to Auctus Fund, LLC (Filed With SEC on March 30, 2022)

Common Stock Purchase Warrant, dated November 9, 2021, issued by BioRestorative Therapies, Inc. pursuant to public offering (Filed With SEC on March 30, 2022)

Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and Francisco Silva (Filed With SEC on March 30, 2022)

Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and Lance Alstodt (Filed With SEC on March 30, 2022)

Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and David Rosa (Filed With SEC on March 30, 2022)

Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and Patrick F. Williams (Filed With SEC on March 30, 2022)

Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and Nickolay Kukekov (Filed With SEC on March 30, 2022)

2,300,000 SHARESOF COMMON STOCK AND 2,300,000 WARRANTS OF BIORESTORATIVE THERAPIES, INC. AMENDED AND RESTATED UNDERWRITING AGREEMENT (Filed With SEC on November 8, 2021)

Form of Underwriting Agreement (Filed With SEC on November 4, 2021)

Form of Investor Warrant (Filed With SEC on November 4, 2021)

Form of Representative Warrant (Filed With SEC on November 4, 2021)

Exchange Agreement, dated as of October 22, 2021, between the Company and Crossover Capital Fund I, LLC (Filed With SEC on October 29, 2021)

Form of Warrant Agency Agreement (Filed With SEC on October 29, 2021)

Form of Investor Warrant (Filed With SEC on October 29, 2021)

EXCHANGE AGREEMENT (Filed With SEC on October 20, 2021)

Exchange Agreement, dated as of October 12, 2021, between BioRestorative Therapies, Inc. and Auctus Fund, LLC, including the form of Certificate of Designations of Series A... (Filed With SEC on October 18, 2021)

Amendment to Silva Employment Agreement, dated April 25, 2019 (Filed With SEC on March 18, 2021)

2010 Equity Participation Plan, as amended (Filed With SEC on March 18, 2021)

PLAN SUPPLEMENT TO AMENDED JOINT PLAN OF REORGANIZATION OF BIORESTORATIVE THERAPIES, INC. AND AUCTUS FUND, LLC (Filed With SEC on November 5, 2020)

SECURED TERM NOTE (Filed With SEC on April 28, 2020)

SECURITY AGREEMENT (Filed With SEC on April 28, 2020)

AMENDED AND RESTATED DIP LOAN AND SECURITY AGREEMENT by and between BIORESTORATIVE THERAPIES, INC., as Borrower and PHOENIX CELL GROUP HOLDINGS, LLC, as Lender Dated: March 30,... (Filed With SEC on April 3, 2020)

AMENDED AND RESTATED STALKING HORSE ASSET PURCHASE AGREEMENT BY AND AMONG PHOENIX CELL GROUP HOLDINGS LLC, a Delaware limited liability company AND BIORESTORATIVE THERAPIES, INC.,... (Filed With SEC on April 3, 2020)

DIP LOAN AND SECURITY AGREEMENT By and Between BIORESTORATICE THERAPIES, INC., as Borrower And PHOENIX CELL GROUP HOLDINGS, LLC, as Lender Dated: March 19, 2020 TABLE OF CONTENTS (Filed With SEC on March 20, 2020)

STALKING HORSE ASSET PURCHASE AGREEMENT1 BY AND AMONG PHOENIX CELL GROUP HOLDINGS LLC, a Delaware limited liability company and BIORESTORATIVE THERAPIES, INC., a Delaware... (Filed With SEC on March 20, 2020)

BioRestorative Therapies, Inc. 40 Marcus Drive Melville, New York 11747 (Filed With SEC on March 20, 2020)

COMMON STOCK PURCHASE WARRANT BIORESTORATIVE THERAPIES, INC. (Filed With SEC on October 10, 2019)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 10, 2019)

Exchange Agreement, dated as of August 8, 2019, between BioRestorative Therapies, Inc. and Harvey P. Alstodt and Merry Alstodt (Filed With SEC on September 6, 2019)

(Filed With SEC on June 24, 2019)

Amendment to Silva Employment Agreement, dated January 5, 2018 (Filed With SEC on March 29, 2019)

Amendment to Paccasassi Employment Agreement, dated March 24, 2016 (Filed With SEC on March 29, 2019)

Amendment to Paccasassi Employment Agreement, dated May 30, 2018 (Filed With SEC on March 29, 2019)

Amendment to Paccasassi Employment Agreement, dated March 1, 2017 (Filed With SEC on March 29, 2019)

Amendment to Silva Employment Agreement, dated May 31, 2018 (Filed With SEC on March 29, 2019)

Executive Employment Agreement, dated as of September 2, 2015, between BioRestorative Therapies, Inc. and Robert Paccasassi (Paccasassi Employment Agreement) (Filed With SEC on March 29, 2019)

Stock Option Agreement, dated as of July 12, 2017, between BioRestorative Therapies, Inc. and Robert Paccasassi (Filed With SEC on March 29, 2019)

Stock Option Agreement, dated as of June 10, 2016, between BioRestorative Therapies, Inc. and Robert Paccasassi (Filed With SEC on March 29, 2019)

Stock Option Agreement, dated as of August 13, 2015, between BioRestorative Therapies, Inc. and Robert Paccasassi (Filed With SEC on March 29, 2019)

Stock Option Agreement, dated as of October 29, 2018, between BioRestorative Therapies, Inc., and Mark Weinreb (Filed With SEC on March 29, 2019)

Convertible Promissory Note, dated October 19, 2018, issued by BioRestorative Therapies, Inc. to Labrys Fund, L.P (Filed With SEC on March 29, 2019)

12% Convertible Redeemable Note, dated November 28, 2018, issued by BioRestorative Therapies, Inc to Eagle Equities, LLC (Filed With SEC on March 29, 2019)

Form of Stock Option Agreement, dated as of October 29, 2018, between BioRestorative Therapies, Inc. and each of Robert B. Catell, John M Desmarais, A. Jeffrey Radov, Charles S.... (Filed With SEC on March 29, 2019)

Stock Option Agreement, dated as of October 29, 2018, between BioRestorative Therapies, Inc., and Francisco Silva (Filed With SEC on March 29, 2019)

Stock Option Agreement, dated as of October 29, 2018, between BioRestorative Therapies, Inc., and Robert Paccasassi (Filed With SEC on March 29, 2019)

Convertible Promissory Note, dated November 12, 2018, issued by BioRestorative Therapies, Inc. to SCG Capital, LLC (Filed With SEC on March 29, 2019)

Letter agreement, dated November 20, 2018, with regard to Desmarais Note (Filed With SEC on March 29, 2019)

Convertible Promissory Note, dated January 18, 2019, issued by BioRestorative Therapies, Inc. to Auctus Fund, LLC (Filed With SEC on March 29, 2019)

Amendment to Weinreb Employment Agreement, dated May 30, 2018 (Filed With SEC on March 29, 2019)

(Filed With SEC on February 22, 2019)

(Filed With SEC on February 11, 2019)

AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 11, 2019)

BIORESTORATIVE THERAPIES, INC. _____________ __, 201_ CONVERTIBLE PROMISSORY NOTE DUE __________ __, 2019 (Filed With SEC on January 10, 2019)

BioRestorative Therapies, Inc. (67)